CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major

被引:255
作者
Belkaid, Y
Von Stebut, E
Mendez, S
Lira, R
Caler, E
Bertholet, S
Udey, MC
Sacks, D
机构
[1] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Dermatol Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.168.8.3992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Standard murine models of cutaneous leishmaniasis, involving s.c. inoculation of large numbers of Leishmania major promastigotes, have not supported an essential role for CD8(+) T cells in the control of primary infection. Recently, a L major model combining two main features of natural transmission, low parasite dose and inoculation into a dermal site, has been established in resistant C57BL/6 mice. In the present studies, C57BL/6 mice with CD8(+) T cell deficiencies, including CD8(-/-) and CD8-depleted mice, failed to control the growth of L. major following inoculation of 100 metacyclic promastigotes into the ear dermis. The resulting dermal pathology was minor and delayed. Lesion formation in wild-type mice was coincident with the killing of parasites in the inoculation site. Both events were associated with the accumulation of CD8(+) T lymphocytes in the skin and with the capacity of CD8(+) T cells recovered from draining lymph nodes or infected dermis to release IFN-gamma following coculture with infected dendritic cells. Reconstitution of resistance to L. major in RAG(-/-) mice using T cells from naive donors was optimal when both CD4(+) and CD8(+) T cells were transferred. Primed CD8(+) T lymphocytes obtained from C57BL/6 mice during the acute stage of infection were able to mediate both pathology and immunity when transferred alone. The low dose, intradermal challenge model reveals that CD8(+) T cells play an essential role in both pathogenesis of and immunity to primary infection with L. major in the skin.
引用
收藏
页码:3992 / 4000
页数:9
相关论文
共 52 条
  • [1] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
    Albert, ML
    Pearce, SFA
    Francisco, LM
    Sauter, B
    Roy, P
    Silverstein, RL
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1359 - 1368
  • [2] Development of a natural model of cutaneous leishmaniasis:: Powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis
    Belkaid, Y
    Kamhawi, S
    Modi, G
    Valenzuela, J
    Noben-Trauth, N
    Rowton, E
    Ribeiro, J
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) : 1941 - 1953
  • [3] A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity
    Belkaid, Y
    Mendez, S
    Lira, R
    Kadambi, N
    Milon, G
    Sacks, D
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (02) : 969 - 977
  • [4] The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
    Belkaid, Y
    Hoffmann, KF
    Mendez, S
    Kamhawi, S
    Udey, MC
    Wynn, TA
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1497 - 1506
  • [5] BELOSEVIC M, 1989, J IMMUNOL, V143, P266
  • [6] CD40 ligand is required for protective cell-mediated immunity to Leishmania major
    Campbell, KA
    Ovendale, PJ
    Kennedy, MK
    Fanslow, WC
    Reed, SG
    Maliszewski, CR
    [J]. IMMUNITY, 1996, 4 (03) : 283 - 289
  • [7] CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-DEFICIENT MICE INITIALLY CONTROL AN INFECTION WITH LEISHMANIA-MAJOR BUT SUCCUMB TO THE DISEASE
    CHAKKALATH, HR
    THEODOS, CM
    MARKOWITZ, JS
    GRUSBY, MJ
    GLIMCHER, LH
    TITUS, RG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) : 1302 - 1308
  • [8] Cook DN, 1999, J IMMUNOL, V162, P5423
  • [9] LEISHMANIA-MAJOR INFECTION IN MICE PRIMES FOR SPECIFIC MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CD8(+) CYTOTOXIC T-CELL RESPONSES
    DACONCEICAOSILVA, F
    PERLAZA, BL
    LOUIS, JA
    ROMERO, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) : 2813 - 2817
  • [10] Langerhans cells that have matured in vivo in the absence of T cells are fully capable of inducing a helper CD4 as well as a cytotoxic CD8 response
    De Creus, A
    Van Beneden, K
    Taghon, T
    Stolz, F
    Debacker, V
    Plum, J
    Leclercq, G
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (02) : 645 - 653